George Golumbeski's first stop out of Cel­gene: Grail; Roivant taps Genen­tech vet Myr­tle Pot­ter for op­er­a­tions role

→ Three months af­ter qui­et­ly slip­ping out the back door at Cel­gene, George Golumbes­ki has tak­en up the pres­i­dent role at the can­cer de­tec­tion start­up Grail in a sim­i­lar­ly dis­creet man­ner. The for­mer BD chief — not­ed for his cen­tral role in a se­ries of deals for the big biotech — re­places Ken Drazan, who has been in the role for a year af­ter serv­ing as chief busi­ness of­fi­cer. Golumbes­ki joins at a time Grail is shak­ing up its C-suite un­der CEO Jen­nifer Cook: On­aiza Cadoret-Manier, who used to man­age Genen­tech’s res­pi­ra­to­ry fran­chise, joins as chief com­mer­cial of­fi­cer; Roche vet Fred Kohler will be­come VP of peo­ple; and ex-Googler An­gela Lai will rise from the VP rank to chief tech­nol­o­gy of­fi­cer.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER